Mural Oncology Statistics
Total Valuation
Mural Oncology has a market cap or net worth of $45.24 million. The enterprise value is -$55.65 million.
Important Dates
The last earnings date was Wednesday, May 14, 2025, after market close.
| Earnings Date | May 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Mural Oncology has 17.27 million shares outstanding. The number of shares has increased by 1.99% in one year.
| Current Share Class | 17.27M |
| Shares Outstanding | 17.27M |
| Shares Change (YoY) | +1.99% |
| Shares Change (QoQ) | +0.58% |
| Owned by Insiders (%) | 1.51% |
| Owned by Institutions (%) | 26.53% |
| Float | 11.28M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.44 |
| P/TBV Ratio | 0.42 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.08, with a Debt / Equity ratio of 0.06.
| Current Ratio | 5.08 |
| Quick Ratio | 4.65 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -74.16 |
Financial Efficiency
Return on equity (ROE) is -76.27% and return on invested capital (ROIC) is -47.72%.
| Return on Equity (ROE) | -76.27% |
| Return on Assets (ROA) | -43.80% |
| Return on Invested Capital (ROIC) | -47.72% |
| Return on Capital Employed (ROCE) | -127.25% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.13M |
| Employee Count | 116 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -26.26% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -26.26% |
| 50-Day Moving Average | 2.40 |
| 200-Day Moving Average | 3.26 |
| Relative Strength Index (RSI) | 56.52 |
| Average Volume (20 Days) | 270,836 |
Short Selling Information
The latest short interest is 965,834, so 5.59% of the outstanding shares have been sold short.
| Short Interest | 965,834 |
| Short Previous Month | 562,784 |
| Short % of Shares Out | 5.59% |
| Short % of Float | 8.56% |
| Short Ratio (days to cover) | 0.07 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -138.61M |
| Pretax Income | n/a |
| Net Income | -130.73M |
| EBITDA | -135.10M |
| EBIT | -138.61M |
| Earnings Per Share (EPS) | -$7.67 |
Full Income StatementBalance Sheet
The company has $107.68 million in cash and $6.78 million in debt, giving a net cash position of $100.90 million or $5.84 per share.
| Cash & Cash Equivalents | 107.68M |
| Total Debt | 6.78M |
| Net Cash | 100.90M |
| Net Cash Per Share | $5.84 |
| Equity (Book Value) | 107.89M |
| Book Value Per Share | 6.25 |
| Working Capital | 94.50M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$128.01 million and capital expenditures -$47,000, giving a free cash flow of -$128.05 million.
| Operating Cash Flow | -128.01M |
| Capital Expenditures | -47,000 |
| Free Cash Flow | -128.05M |
| FCF Per Share | -$7.42 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |